Vanguard Group Inc Revolution Medicines, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 14,911,373 shares of RVMD stock, worth $646 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,911,373

Previous 14,378,297 3.71%

Holding current value

$646 Million

Previous $558 Million 21.08%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$36.92 - $47.94 $19.7 Million - $25.6 Million	533,076 Added 3.71%	14,911,373 $676 Million
Q2 2024 Aug 13, 2024	SELL	$30.14 - $40.68 $11.4 Million - $15.4 Million	-378,815 Reduced 2.57%	14,378,297 $558 Million
Q1 2024 May 10, 2024	BUY	$26.56 - $33.55 $3.26 Million - $4.12 Million	122,721 Added 0.84%	14,757,112 $476 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $91.6 Million - $170 Million	4,990,800 Added 51.75%	14,634,391 $420 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $7.63 Million - $10.6 Million	303,088 Added 3.24%	9,643,591 $267 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $769,626 - $1.02 Million	37,950 Added 0.41%	9,340,503 $250 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $36.1 Million - $52.4 Million	1,740,643 Added 23.02%	9,302,553 $201 Million
Q4 2022 Feb 10, 2023	BUY	$17.68 - $25.53 $10.2 Million - $14.8 Million	577,908 Added 8.27%	7,561,910 $180 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $24.7 Million - $36.8 Million	1,416,990 Added 25.45%	6,984,002 $138 Million
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $7.14 Million - $13.3 Million	-490,919 Reduced 8.1%	5,567,012 $109 Million
Q1 2022 May 13, 2022	SELL	$17.31 - $26.4 $4.18 Million - $6.38 Million	-241,678 Reduced 3.84%	6,057,931 $155 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $1.45 Million - $2 Million	59,411 Added 0.95%	6,299,609 $159 Million
Q3 2021 Nov 12, 2021	BUY	$23.95 - $33.41 $23.3 Million - $32.5 Million	971,634 Added 18.44%	6,240,198 $172 Million
Q2 2021 Aug 13, 2021	BUY	$29.0 - $47.44 $153 Million - $250 Million	5,268,564 New	5,268,564 $167 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Revolution Medicines, Inc. Transaction History